, Volume 194, Issue 3, pp 371–379 | Cite as

Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls

  • Rosa HoshiEmail author
  • Kate Mullins
  • Catherine Boundy
  • Catherine Brignell
  • Paula Piccini
  • H. Valerie Curran
Original Investigation



Despite years of research and much controversy surrounding the effects of ecstasy use, findings are equivocal. Attempting to reduce methodological problems, such as concurrent use of other recreational drugs, could lead to a clearer picture of the effects of ecstasy use on cognitive function.


The aim of this study is to investigate the effects of both prolonged abstention from ecstasy use and current use on cognitive function while controlling for the regular use of other recreational drugs used by ecstasy users (alcohol, cannabis, cocaine, amphetamines and lysergic acid diethylamide).

Materials and methods

A range of cognitive functions (including working memory, episodic memory, verbal learning and executive functions) was assessed in 109 participants: 25 current ecstasy users, 28 ex-ecstasy users (abstinent for at least 1 year), 29 polydrug-using controls (matched to both ecstasy-using groups for the use of other recreational drugs) and 27 drug-naïve controls.


There was an overall tendency for impaired verbal learning and memory in both current ecstasy users and polydrug controls. There was also evidence of reduced response inhibition in the current ecstasy users and polydrug controls, which appeared to be related to recency of drug use. However, the majority of tests showed no group differences.


The results suggest that recreational drug use in general, rather than ecstasy use per se, can lead to subtle cognitive impairments and that recent drug use appears to impact strongest on cognitive performance. This study highlights the importance of controlling for the use of all recreational drugs and, in particular, recent drug use when investigating ‘effects of ecstasy’ on cognitive function.


Ecstasy MDMA Cognitive function Polysubstance use Recreational drug use 



RH was supported by a Medical Research Council (UK) studentship.


  1. Allott K, Redman J (2007) Are there sex differences associated with the effects if ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? Neurosci Biobehav Rev 31:327–347PubMedCrossRefGoogle Scholar
  2. Barratt E, Patton JH (1983) Impulsivity: cognitive, behavioural and psychophysiological correlates. In: Zuckerman M (ed) Biological basis of sensation feeling, impulsivity and anxiety. Erlbaum, Hillsdale, NJGoogle Scholar
  3. Beck AT (1978) The Beck Depression Inventory (BDI). The Psychological Corporation. Harcourt Brace Jovanovitz, Orlando, FL, USAGoogle Scholar
  4. Bhattachary S, Powell JH (2001) Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’: evidence for cognitive impairment. Psychol Med 31:647–658PubMedCrossRefGoogle Scholar
  5. Buschke H, Fuld PA (1974) Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 11:1019–1025Google Scholar
  6. Buss A, Perry M (1992) The aggression questionnaire. J Pers Soc Psychol 63:452–459PubMedCrossRefGoogle Scholar
  7. Croft R, Mackay A, Mills A, Gruzelier G (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153:373–379PubMedCrossRefGoogle Scholar
  8. Curran H, Verheyden S (2003) Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Psychopharmacology 169:91–103PubMedCrossRefGoogle Scholar
  9. Dafters R, Hoshi R, Talbot AC (2004) Contribution of cannabis and MDMA (“ecstasy”) to cognitive changes in long-term poly-drug users. Psychopharmacology 173:405–410PubMedCrossRefGoogle Scholar
  10. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2005) News release no. 9: cocaine, amphetamines, ecstasy and cannabis: latest trends. Novermber 24, LisbonGoogle Scholar
  11. Fisk J, Montgomery C, Wareing M, Murphy PN (2005) Reasoning deficits in ecstasy (MDMA) polydrug users. Psychopharmacology 181:550–559PubMedCrossRefGoogle Scholar
  12. Gibson H (1977) Manual of the Gibson Spiral Maze, 2nd edn. Hodder, London, UKGoogle Scholar
  13. Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Henson G, Daumann J (2005) Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. Drug Alcohol Depend 78:317–323CrossRefGoogle Scholar
  14. Green A, Mechan AO, Elliot JM, O’Shea E, Colado IM (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’). Pharmacol Rev 55:463–508PubMedCrossRefGoogle Scholar
  15. Hanson K, Luciana M (2004) Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Psychol Med 34:229–246PubMedCrossRefGoogle Scholar
  16. Hatzidimitriou G, McCann U, Ricaurte G (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with 3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096–5107PubMedGoogle Scholar
  17. Lundqvist T (2005) Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav 81:319–330PubMedCrossRefGoogle Scholar
  18. Morgan M, McFie L, Fleetwood L, Robinson J (2002) Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 159:294–303PubMedCrossRefGoogle Scholar
  19. Owen A, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990) Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 28:1021–1034PubMedCrossRefGoogle Scholar
  20. Owen A, Sahakian BJ, Semple J, Polkey CE, Robbins TW (1995) Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 33:1–24PubMedCrossRefGoogle Scholar
  21. Reitan RM (1959) A manual for the administration and scoring of the Trail Making Test. Indiana University Press, Indianapolis, USAGoogle Scholar
  22. Riedel W, Klaassen T, Deutz NEP, van Someren A, van Praag HM (1999) Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology 141:362–369PubMedCrossRefGoogle Scholar
  23. Roiser JP, Rogers RD, Cook LJ, Sahakian BJ (2006) The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Psychopharmacology 118:213–227CrossRefGoogle Scholar
  24. Roiser J, Rogers RD, Sahakian BJ (2007) Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology 189:505–516PubMedCrossRefGoogle Scholar
  25. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. J Am Med Assoc 287:1123–1131CrossRefGoogle Scholar
  26. Speilberger C, Garsuch R, Lushene R (1970) Manual for the state-trait anxiety inventory. Consulting Psychologists Press, Palo Alto, CaliforniaGoogle Scholar
  27. Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy users. Psychopharmacology 167:85–96PubMedGoogle Scholar
  28. Verkes R, Gijsman H, Pieters M, Schoemaker R, de Visser S, Kuijpers M, Pennings E, de Bruin D, Van de Wijngaart G, Van Gerven J, Cohen A (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153:196–202PubMedCrossRefGoogle Scholar
  29. Wareing M, Murphy PN, Fisk JE (2004) Visuospatial memory impairments in users of MDMA (‘ecstasy’). Psychopharmacology 173:391–397PubMedCrossRefGoogle Scholar
  30. Wesnes K, Warburton DM (1983) Effects of smoking on rapid visual information processing performance. Neuropsychobiology 9:229–233Google Scholar
  31. Wilson, B, Cockburn J, Baddeley A (1985) The Rivermead Behavioural Memory test. Thames Valley Text, Reading, UKGoogle Scholar
  32. Yip J, Lee TMC (2005) Effects of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology 179:620–628PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Rosa Hoshi
    • 1
    Email author
  • Kate Mullins
    • 1
  • Catherine Boundy
    • 1
  • Catherine Brignell
    • 2
  • Paula Piccini
    • 3
  • H. Valerie Curran
    • 1
  1. 1.Clinical Psychopharmacology Unit, Sub-department of Clinical Health PsychologyUniversity College LondonLondonUK
  2. 2.School of PsychologyUniversity of SouthamptonSouthamptonUK
  3. 3.MRC Clinical Sciences Centre and Division of Neurosciences, Hammersmith HospitalImperial College LondonLondonUK

Personalised recommendations